Transforming Alzheimer’s Disease Diagnosis with the PrecivityAD2™ Blood Test: Seeking to Establish a New Clinical Care Standard for Patients with Memory Impairment

Overview

Transforming Alzheimer’s Disease Diagnosis with the PrecivityAD2™ Blood Test
Learning objectives include:
- Leveraging a single test that has high concordance with CSF analysis and amyloid PET scans1-3
- Removing diagnostic testing barriers with a simple blood draw
- Gaining accurate insights with a clinically-validated algorithm that combines Aβ42/40 and p-tau217/np-tau217 (%p-tau217) ratios